Pep supports many GLP-1 medications including Ozempic, Wegovy, Zepbound, Mounjaro, Rybelsus, and compounded GLP-1 medications
[11] Tirzepatide is a prescription medication approved by the FDA for the treatment of type 2 diabetes (under the brand name Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (under the brand name Zepbound)
The most common side effects reported by patients are mild to moderate gastrointestinal symptoms, such as nausea, vomiting, diarrhea, and constipation
8 Over time, elevated blood sugar levels can result in a range of health complications affecting multiple organ systems, including the heart, kidneys, feet, and retina
That 200-pound person could expect to lose 30 to 42 pounds on average